Rheumatoid Arthritis
Overview of Rheumatoid Arthritis
Diabetes, weight loss drugs emerging as treatment pathway in rheumatology
Drugs used to treat diabetes and obesity, such as GLP-1 receptor agonists, are becoming an important treatment pathway in rheumatology, according to a presenter at the 2024 Association of Women in Rheumatology annual conference.
Biosimilars as effective as originator drugs in rheumatoid arthritis treatment
Biosimilars have shown to be just as effective as original brand name medications in treating rheumatoid arthritis, and the former may be more cost-effective for patients.
CAR T cells one year later: What have we learned?
Nearly 1 year ago, I wrote my first editorial about the emergence and excitement surrounding the early experience with CAR T cells — CAR T Cells in Autoimmunity: A Potential Therapy About to Explode.
‘Silver tsunami’ likely to have significant impacts for rheumatology providers
ORLANDO, Fla. — The aging process can cause a significant decline in the immune system, a process set to impact a growing proportion of the general population and rheumatic patients alike, according to a presenter here.
Forefoot ‘can be omitted’ when using ultrasound to predict rheumatoid arthritis
Forefoot ultrasound adds little value when attempting to predict rheumatoid arthritis in patients with clinically suspect arthralgia, as positive findings there are “rare” without accompanying inflammation in the hands, according to data.
Gout
Optimal adherence to TNF inhibitors for rheumatoid arthritis may be 60% of days covered
Greater adherence to TNF inhibitor therapy for rheumatoid arthritis led to fewer adverse events, with the optimal adherence threshold being approximately 60% of days covered, according to data published in Clinical Rheumatology.